Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.

ABSTRACT: Advances in the field of cancer immunotherapy have occurred rapidly over the past decade. Exciting results from clinical trials have led to new treatment options and improved survival for patients with a myriad of solid tumor pathologies. However, questions remain unanswered regarding duration and timing of therapy, combination regimens, appropriate biomarkers of disease, and optimal monitoring of therapeutic response. This article reviews emerging immunotherapeutic agents and significant clinical trials that have led to advancements in the field of immuno-oncology for patients with head and neck squamous cell carcinoma.

Implications for practice

This review article summarizes recently developed agents that harness the immune system to fight head and neck squamous cell carcinoma. A

SUBMITTER: Moskovitz JM 

PROVIDER: S-EPMC5469583 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature